Pharmacokinetics and Pharmacodynamics of Oral Transmucosal Dexmedetomidine.

NCT03120247 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Sedation

Interventions

DRUG: OTM Dexmedetomidine 1µg/ kg.
DRUG: OTM Dexmedetomidine 0.75µg/ kg.
DRUG: OTM Dexmedetomidine 0.5µg/ kg.

Sponsor

Assiut University